San Diego, CA, United States of America

Nicholas Sam-Soon

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Zafrens, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nicholas Sam-Soon

Introduction

Nicholas Sam-Soon is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of drug discovery through his innovative work on perturbation beads. His unique approach has the potential to enhance the accuracy and efficiency of assays conducted in mapped assay devices.

Latest Patents

Nicholas holds a patent for "Perturbation beads for use in assays." This invention discloses uniquely labeled perturbation beads that can be used alone or in combination with a capture bead. These beads are particularly useful in drug discovery, allowing for the correlation of nucleic acids and other components from lysed cells to specific examination areas within a mapped assay device. He has 1 patent to his name.

Career Highlights

Nicholas has built a career focused on innovative solutions in the biotechnology sector. His work at Zafrens, Inc. has positioned him as a key player in the development of advanced assay technologies. His contributions are paving the way for more effective drug discovery processes.

Collaborations

Nicholas collaborates with talented individuals such as Kandaswamy Vijayan and Ravi Ramenani. Together, they work towards advancing the capabilities of assay technologies and improving drug discovery methodologies.

Conclusion

Nicholas Sam-Soon's innovative work in the field of drug discovery exemplifies the impact of creativity and technology in science. His contributions through his patent on perturbation beads are set to enhance the efficiency of assays, making significant strides in the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…